QUEST DIAGNOSTICS INC
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
DGX$258.44-0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders' Equity
| Quest Diagnostics Stockholders’ Equity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares ofCommonStock Out-standing · CommonStock · AdditionalPaid-InCapital · RetainedEarnings · AccumulatedOtherComprehensive Loss · TreasuryStock, atCost · Non-controllingInterests · Total Stock-holders’Equity | |||||||||||
| Balance, December 31, 2021 | 119 | $2 | $2,260 | $7,649 | $(14) | $(3,453) | $39 | $6,483 | |||
| Net income | 946 | 62 | 1,008 | ||||||||
| Other comprehensive loss, net of tax | (7) | (7) | |||||||||
| Dividends declared | (305) | (305) | |||||||||
| Distributions to noncontrolling interest partners | (64) | (64) | |||||||||
| Issuance of common stock under benefit plans | 1 | (36) | 64 | 28 | |||||||
| Stock-based compensation expense | 77 | 77 | |||||||||
| Exercise of stock options | 1 | 4 | 119 | 123 | |||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (10) | (18) | (28) | ||||||||
| Purchases of treasury stock | (10) | (1,385) | (1,385) | ||||||||
| Balance, December 31, 2022 | 111 | $2 | $2,295 | $8,290 | $(21) | $(4,673) | $37 | $5,930 | |||
| Net income | 854 | 49 | 903 | ||||||||
| Other comprehensive income, net of tax | 7 | 7 | |||||||||
| Dividends declared | (319) | (319) | |||||||||
| Distributions to noncontrolling interest partners | (51) | (51) | |||||||||
| Issuance of common stock under benefit plans | 1 | (39) | 66 | 27 | |||||||
| Stock-based compensation expense | 77 | 77 | |||||||||
| Exercise of stock options | 1 | (3) | 75 | 72 | |||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (10) | (18) | (28) | ||||||||
| Purchases of treasury stock | (2) | (276) | (276) | ||||||||
| Balance, December 31, 2023 | 111 | $2 | $2,320 | $8,825 | $(14) | $(4,826) | $35 | $6,342 | |||
| Net income | 871 | 43 | 914 | ||||||||
| Other comprehensive loss, net of tax | (74) | (74) | |||||||||
| Dividends declared | (336) | (336) | |||||||||
| Distributions to noncontrolling interest partners | (43) | (43) | |||||||||
| Issuance of common stock under benefit plans | (38) | 64 | 26 | ||||||||
| Stock-based compensation expense | 88 | 88 | |||||||||
| Exercise of stock options | 1 | 73 | 73 | ||||||||
| Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans | (6) | (18) | (24) | ||||||||
| Acquisition of additional ownership interest in subsidiary | (3) | (3) | |||||||||
| Purchases of treasury stock | (1) | (150) | (150) | ||||||||
| Balance, December 31, 2024 | 111 | $2 | $2,361 | $9,360 | $(88) | $(4,857) | $35 | $6,813 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.